Table 4 Stillbirths to women admitted to hospital with symptomatic SARS-CoV-2 by dominant variant period and severity of maternal infection, March 1, 2020, to March 31, 2022, United Kingdom
From: Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study
SARS-CoV-2 dominant variant | Wild-type period | Alpha period | Delta period | Omicron period | ||||
|---|---|---|---|---|---|---|---|---|
Severitya | Mild (N = 1067) | Moderate to severea (N = 370) | Mild (N = 1220) | Moderate to severea (N = 678) | Mild (N = 1420) | Moderate to severea (N = 1055) | Mild (N = 1098) | Moderate to severea (N = 208) |
Stillbirths - no. (%) | 9 (0.8) | 6 (1.6) | 12 (1.0) | 9 (1.3) | 42 (3.0) | 20 (1.9) | 8 (0.7) | 5 (2.4) |
Model 1b: RR (95% CI) | [Ref] | 1.93 (0.68–5.38) | 1.17 (0.49–2.76) | 1.57 (0.63–3.95) | 3.49 (1.70–7.18) | 2.25 (1.03–4.92) | 0.86 (0.32–2.34) | 2.86 (0.96–8.46) |
Model 2c: RR (95% CI) | [Ref] | 1.90 (0.61–5.88) | 1.20 (0.49–2.97) | 1.68 (0.63–4.51) | 3.57 (1.66–7.67) | 2.41 (1.03–5.60) | 0.96 (0.35–2.66) | 2.62 (0.79–8.69) |
Model 3d: RR (95% CI) | NA | NA | [Ref] | 0.99 (0.33–3.01) | 2.82 (1.29–6.16) | 1.89 (0.81–4.40) | 0.79 (0.25–2.47) | 2.07 (0.64–6.76) |